Evaluation of two CE-IVD tests for BCR-ABL1 transcript monitoring of chronic myeloid leukemia patients

被引:0
|
作者
Folta, Adam [1 ]
Jurcek, Tomas [1 ]
Kubesova, Blanka [1 ]
Zackova, Daniela [1 ,2 ]
Semerad, Lukas [1 ,2 ]
Mayer, Jiri [1 ,2 ,3 ]
Jeziskova, Ivana [1 ,2 ]
机构
[1] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Jihlavska 20, Brno 62500, Czech Republic
[2] Masaryk Univ, Fac Med, Dept Internal Med Hematol & Oncol, Brno, Czech Republic
[3] Masaryk Univ, Cent European Inst Technol CEITEC, Brno, Czech Republic
关键词
RESIDUAL DISEASE; STANDARDIZATION; ASSAY;
D O I
10.1080/10428194.2020.1861274
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1239 / 1242
页数:4
相关论文
共 50 条
  • [31] Clinicopathological Variables and Outcome in Chronic Phase Chronic Myeloid Leukemia Associated with BCR-ABL1 Transcript Type and Obesity
    Abdulla, Mohammad Abdul-Jaber
    Chandra, Prem
    El Akiki, Susana
    Sorio, Claudio
    Tomasello, Luisa
    Boni, Christian
    Yassin, Mohamed A.
    BLOOD, 2020, 136
  • [32] BCR-ABL1 transcript levels increase in peripheral blood but not in granulocytes after physical exercise in patients with chronic myeloid leukemia
    Jonsson, Sofia
    Olsson, Bob
    Jacobsson, Stefan
    Palmqvist, Lars
    Ricksten, Anne
    Ekeland-Sjoberg, Kerstin
    Wadenvik, Hans
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2011, 71 (01): : 7 - 11
  • [33] Variant e19a2 BCR-ABL1 Fusion Transcript in Typical Chronic Myeloid Leukemia
    Tutulan-Cunita, Andreea Cristina
    Chirieac, Sorina Mihaela
    Mocanu, Gabriela
    Luca, Catalina
    Costache, Marieta
    Lungeanu, Agripina
    Arghir, Aurora
    CLINICAL LABORATORY, 2011, 57 (9-10) : 785 - 788
  • [34] The BCR-ABL1 Transcript Type Does Not Influence the Response and the Outcome of Chronic Myeloid Leukemia Patients Treated Frontline with Nilotinib
    Castagnetti, Fausto
    Gugliotta, Gabriele
    Palandri, Francesca
    Breccia, Massimo
    Stagno, Fabio
    Levato, Luciano
    Fava, Carmen
    Luciano, Luigiana
    Intermesoli, Tamara
    Cedrone, Michele
    Carella, Angelo Michele
    Cavazzini, Francesco
    Turri, Diamante
    Avanzini, Paolo
    Pierri, Ivana
    Lunghi, Monia
    Venturi, Claudia
    Soverini, Simona
    Testoni, Nicoletta
    Alimena, Giuliana
    Saglio, Giuseppe
    Martinelli, Giovanni
    Pane, Fabrizio
    Baccarani, Michele
    Rosti, Gianantonio
    BLOOD, 2012, 120 (21)
  • [35] THE IMPACT OF DIFFERENT BCR-ABL1 TRANSCRIPT ON OUTCOME OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS: A MONOCENTRIC REAL LIFE EXPERIENCE
    Farina, M.
    D'adda, M.
    Schieppati, F.
    Cerqui, E.
    Rossi, G.
    HAEMATOLOGICA, 2017, 102 : 21 - +
  • [36] Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia
    Z Gong
    L J Medeiros
    J E Cortes
    L Zheng
    J D Khoury
    W Wang
    G Tang
    S Loghavi
    R Luthra
    W Yang
    H M Kantarjian
    S Hu
    Blood Cancer Journal, 2017, 7 : e583 - e583
  • [37] Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia
    Gong, Z.
    Medeiros, L. J.
    Cortes, J. E.
    Zheng, L.
    Khoury, J. D.
    Wang, W.
    Tang, G.
    Loghavi, S.
    Luthra, R.
    Yang, W.
    Kantarjian, H. M.
    Hu, S.
    BLOOD CANCER JOURNAL, 2017, 7 : e583 - e583
  • [38] UK NEQAS LI BCR-ABL1 Quantitation Programme: impact of UK guidelines for BCR-ABL1 transcript quantitation in chronic myeloid leukaemia
    Clark, J. R.
    Jack, A. L.
    Barnett, D.
    Reilly, J. T.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 : 82 - 82
  • [39] ASSOCIATION OF HLA ANTIGENS AND BCR-ABL1 TRANSCRIPTS IN ETHIOPIAN CHRONIC MYELOID LEUKEMIA PATIENTS
    Birru, Samuel
    Lehmann, Claudia
    Doxiadis, Ilias
    Cross, Michael
    HLA, 2021, 98 : 4 - 5
  • [40] STUDY OF MUTATIONS IN THE KINASE DOMAIN OF BCR-ABL1 BY NGS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Stuckey, Ruth
    Florido, Ortega Yanira
    Rodriguez, Lopez Juan Francisco
    Bilbao, Sieyro Cristina
    Gomez, Casares Maria Teresa
    HAEMATOLOGICA, 2020, 105 : 239 - 239